BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 16797967)

  • 1. Elderly patients with rectal cancer have a higher risk of treatment-related complications and a poorer prognosis than younger patients: a population-based study.
    Shahir MA; Lemmens VE; van de Poll-Franse LV; Voogd AC; Martijn H; Janssen-Heijnen ML
    Eur J Cancer; 2006 Nov; 42(17):3015-21. PubMed ID: 16797967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival of elderly rectal cancer patients not improved: analysis of population based data on the impact of TME surgery.
    Rutten H; den Dulk M; Lemmens V; Nieuwenhuijzen G; Krijnen P; Jansen-Landheer M; van de Poll Franse L; Coebergh JW; Martijn H; Marijnen C; van de Velde C
    Eur J Cancer; 2007 Oct; 43(15):2295-300. PubMed ID: 17709242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anaemia prior to operation is related with poorer long-term survival in patients with operable rectal cancer.
    van Halteren HK; Houterman S; Verheij CD; Lemmens VE; Coebergh JW
    Eur J Surg Oncol; 2004 Aug; 30(6):628-32. PubMed ID: 15256236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complications and survival after surgery for rectal cancer in patients younger than and aged 75 years or older.
    Vironen JH; Sainio P; Husa AI; Kellokumpu IH
    Dis Colon Rectum; 2004 Jul; 47(7):1225-31. PubMed ID: 15164247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efforts to improve local control in rectal cancer compromise survival by the potential morbidity of optimal mesorectal excision.
    Laurent C; Nobili S; Rullier A; Vendrely V; Saric J; Rullier E
    J Am Coll Surg; 2006 Nov; 203(5):684-91. PubMed ID: 17084330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors that influence the adequacy of total mesorectal excision for rectal cancer.
    Jeyarajah S; Sutton CD; Miller AS; Hemingway D;
    Colorectal Dis; 2007 Nov; 9(9):808-15. PubMed ID: 17441969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for adverse outcome in patients with rectal cancer treated with an abdominoperineal resection in the total mesorectal excision trial.
    den Dulk M; Marijnen CA; Putter H; Rutten HJ; Beets GL; Wiggers T; Nagtegaal ID; van de Velde CJ
    Ann Surg; 2007 Jul; 246(1):83-90. PubMed ID: 17592295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved overall survival for patients with rectal cancer since 1990: the effects of TME surgery and pre-operative radiotherapy.
    den Dulk M; Krijnen P; Marijnen CA; Rutten HJ; van de Poll-Franse LV; Putter H; Meershoek-Klein Kranenbarg E; Jansen-Landheer ML; Coebergh JW; van de Velde CJ
    Eur J Cancer; 2008 Aug; 44(12):1710-6. PubMed ID: 18573654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma.
    Peeters KC; Marijnen CA; Nagtegaal ID; Kranenbarg EK; Putter H; Wiggers T; Rutten H; Pahlman L; Glimelius B; Leer JW; van de Velde CJ;
    Ann Surg; 2007 Nov; 246(5):693-701. PubMed ID: 17968156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Introduction of preoperative radiotherapy in the treatment of operable rectal cancer in the Southwest region of the Netherlands.
    Vermaas M; Gosselink MP; Ferenschild FT; van den Aardweg E; Lont HE; Kemperman HW; van der Harst E; Tetteroo GW; Oostenbroek RJ; Dijkhuis CM; Eggermont AM; de Wilt JH
    Eur J Surg Oncol; 2007 Sep; 33(7):862-7. PubMed ID: 17257804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Greater influence of age than co-morbidity on primary treatment and complications of prostate cancer patients: an in-depth population-based study.
    Houterman S; Janssen-Heijnen ML; Verheij CD; Kil PJ; van den Berg HA; Coebergh JW
    Prostate Cancer Prostatic Dis; 2006; 9(2):179-84. PubMed ID: 16534509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of total mesorectal excision on local recurrence and survival in rectal cancer patients: a population-based study in Greater Amsterdam.
    Visser O; Bakx R; Zoetmulder FA; Levering CC; Meijer S; Slors JF; van Lanschot JJ
    J Surg Oncol; 2007 May; 95(6):447-54. PubMed ID: 17048237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of treatment outcome by CD44v6 after total mesorectal excision in locally advanced rectal cancer.
    Peng J; Lu JJ; Zhu J; Xu Y; Lu H; Lian P; Cai G; Cai S
    Cancer J; 2008; 14(1):54-61. PubMed ID: 18303484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comorbidity in older surgical cancer patients: influence on patient care and outcome.
    Janssen-Heijnen ML; Maas HA; Houterman S; Lemmens VE; Rutten HJ; Coebergh JW
    Eur J Cancer; 2007 Oct; 43(15):2179-93. PubMed ID: 17681780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Less extensive treatment and inferior prognosis for breast cancer patient with comorbidity: a population-based study.
    Louwman WJ; Janssen-Heijnen ML; Houterman S; Voogd AC; van der Sangen MJ; Nieuwenhuijzen GA; Coebergh JW
    Eur J Cancer; 2005 Mar; 41(5):779-85. PubMed ID: 15763655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined-modality therapy with sphincter-preserving total mesorectal excision for locally advanced rectal cancer: patient's age and long-term outcome.
    Szynglarewicz B; Matkowski R; Maciejczyk A; Kasprzak P; Forgacz J; Pudelko M
    J Gastrointestin Liver Dis; 2008 Mar; 17(1):49-52. PubMed ID: 18392244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benefits and drawbacks of short-course preoperative radiotherapy in rectal cancer patients aged 75 years and older.
    Maas HA; Lemmens VE; Nijhuis PH; de Hingh IH; Koning CC; Janssen-Heijnen ML
    Eur J Surg Oncol; 2013 Oct; 39(10):1087-93. PubMed ID: 23958151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of age and comorbidity on receiving radiotherapy as part of primary treatment for cancer in South Netherlands, 1995 to 2002.
    Vulto AJ; Lemmens VE; Louwman MW; Janssen-Heijnen ML; Poortmans PH; Lybeert ML; Coebergh JW
    Cancer; 2006 Jun; 106(12):2734-42. PubMed ID: 16703598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiation therapy for prostate cancer increases subsequent risk of bladder and rectal cancer: a population based cohort study.
    Nieder AM; Porter MP; Soloway MS
    J Urol; 2008 Nov; 180(5):2005-9; discussion 2009-10. PubMed ID: 18801517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for anastomotic leakage after preoperative chemoradiation therapy and low anterior resection with total mesorectal excision for locally advanced rectal cancer.
    Rodríguez-Ramírez SE; Uribe A; Ruiz-García EB; Labastida S; Luna-Pérez P
    Rev Invest Clin; 2006; 58(3):204-10. PubMed ID: 16958295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.